M A Cano-Cruz

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Sorry, we do not have enough data to show an influence graph for this author.
Learn More
Development of atypical antipsychotic compounds is an important task in pharmacology in order to improve therapeutic features and avoid side effects shown by classical antipsychotic compounds. The prototype of the second generation compounds, clozapine differs from typical antipsychotics by having a high D4 and 5HT(2A) and low D2 receptor affinity.(More)
  • 1